5
Pharmaceutical preparations for the treatment of blood disorders, cardiovascular disease, central nervous system diseases and disorders, diabetes, gastrointestinal disorders, immunological disorders, infectious diseases, inflammation, inflammatory diseases, metabolic diseases, neurological disorders, pain, and respiratory diseases; pharmaceutical preparations used to provide palliative care in the treatment of diseases and disorders; and pharmaceutical preparations used to enhance the digestibility, release characteristics, pharmacological effect, pharmacodynamic effect, solubility, administration, dosing, safety, permeability, targeting, and the stability of therapeutic drugs used in the treatment of blood disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, diabetes, gastrointestinal disorders, immunological disorders, infectious diseases, inflammation, inflammatory diseases, metabolic diseases, neurological disorders, pain, and respiratory diseases